Summary of the safety and tolerability of two treatment regimens of ceftaroline fosamil: 600 mg every 8 h versus 600 mg every 12 h

por Cheng, Karen, Pypstra, Rienk, Yan, Jean Li, Hammond, Jennifer
Publicado 2019

786. Effect of Nirmatrelvir/Ritonavir versus Placebo on COVID-19─Related Hospitalizations and Other Medical Visits

por Hammond, Jennifer, Leister-Tebbe, Heidi, Gardner, Annie, Abreu, Paula, Bao, Weihang, Wisemandle, Wayne, Ansari, Wajeeha, Simón Campos, Jesus Abraham, Pypstra, Rienk, Rusnak, James M
Publicado 2022

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19

por Hammond, Jennifer, Leister-Tebbe, Heidi, Gardner, Annie, Abreu, Paula, Bao, Weihang, Wisemandle, Wayne, Baniecki, MaryLynn, Hendrick, Victoria M., Damle, Bharat, Simón-Campos, Abraham, Pypstra, Rienk, Rusnak, James M.
Publicado 2022

2893 A. Efficacy and Safety of Aztreonam-Avibactam for the Treatment of Serious Infections Due to Gram-Negative Bacteria, Including Metallo-β-Lactamase-Producing Pathogens: Phase 3...

por Carmeli, Yehuda, Cisneros, Jose-Miguel, Paul, Mical, Daikos, Georgios L, Wang, Minggui, Cisneros, Julian Torre, Singer, George, Titov, Ivan, Gumenchuk, Illia, Zhao, Yongjie, Jiménez Rodríguez, Rosa-María, Liang, Lu, Chen, Gang, Pyptiuk, Oleksandr, Aksoy, Firdevs, Rogers, Halley, Wible, Michele, Arhin, Francis, Luckey, Alison, Leaney, Joanne, Pypstra, Rienk, Chow, Joseph
Publicado 2023